TSC1 R509X Mutation in a Chinese Family with Tuberous Sclerosis Complex

Neuromolecular Med. 2015 Jun;17(2):202-8. doi: 10.1007/s12017-015-8354-x. Epub 2015 Apr 22.

Abstract

Tuberous sclerosis complex is a rare autosomal dominant disorder caused by mutations in either of TSC1 and TSC2 genes. Tuberous sclerosis complex presents diverse clinical characteristics, and either of TSC1 and TSC2 genes shows a wide range of mutations in their coding regions. However, the correlation between genotype and phenotype is yet unknown. We describe the clinical characteristics of a Chinese family with TSC1 gene mutation and present a literature review of Chinese patients with tuberous sclerosis complex gene mutation reported since 2004. This is the first report of TSC1 R509X mutation in a Chinese family, which might deepen our insight into the clinical and molecular pathogenesis of tuberous sclerosis complex.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Amino Acid Substitution*
  • Anticonvulsants / therapeutic use
  • Asian People / genetics*
  • Biopsy
  • Brain / diagnostic imaging
  • Brain / pathology
  • Child
  • China / epidemiology
  • Epilepsy, Absence / drug therapy
  • Epilepsy, Absence / genetics
  • Female
  • Genes, Dominant
  • Humans
  • Male
  • Mutation, Missense*
  • Pedigree
  • Phenotype
  • Point Mutation*
  • Radiography
  • Tuberous Sclerosis / ethnology
  • Tuberous Sclerosis / genetics*
  • Tuberous Sclerosis / pathology
  • Tuberous Sclerosis Complex 1 Protein
  • Tumor Suppressor Proteins / genetics*

Substances

  • Anticonvulsants
  • TSC1 protein, human
  • Tuberous Sclerosis Complex 1 Protein
  • Tumor Suppressor Proteins